Clinical TrialsSearch results
Number of results: 386
Recruiting
- Characteristics of logical reasoning skills and intervention effects in children with developmental disabilities: a computer based program approach
- Autism spectrum disorder
- Kotegawa Kohei
- 2022-08-26
Not yet recruiting
- Prospective randomized trial for success rate of left bundle branch pacing comparing anatomical to electrical guided lead placement
- Bradycardia
- Tsurugi Takuo
- 2022-06-18
Recruiting
- A Study of Teclistamab in Combination with Daratumumab Subcutaneously (SC) (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Nishikawa Kazuk
- 2022-03-02
Completed
- Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
- Amyotrophic Lateral Sclerosis
- Kondo Kazuoki
- 2022-01-21
Other
- TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
- Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Asato Takayuki
- 2021-12-12
Recruiting
- Phase 3 Study to Evaluate BIIB059 in Active SLE (TOPAZ-II Study)
- Systemic Lupus Erythematosus
- Cho Kyo
- 2021-11-01
Recruiting
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease
- Crohn's Disease
- Shikamura Mitsuhiro
- 2021-06-01
Recruiting
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis
- Colitis, Ulcerative
- Shikamura Mitsuhiro
- 2021-05-31
Completed
- A Study to Evaluate the Efficacy and Safety of ION-682884 in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
- Hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN)
- Viney Nick
- 2021-04-12
Completed
- Feasibility study of adjuvant chemotherapy with cisplatin(CDDP) and TS-1 in followed by alternate-day treatment with TS-1 in patients with completely resected pathological II-IIIA non small cell lung cancer
- Non-small cell lung cancer
- Suzuki Makoto
- 2019-03-29